Speakers of both Conferences

Dr Andrew Bartko, Battelle Memorial Institute, USA

Dr Andrew P. Bartko received a B.S. from the University of Pittsburgh and a Ph.D. in physical chemistry. He is a senior scientist in Battelle’s Technology Development Group. the manager and technical leader of an interdisciplinary team that is developing Battelle’s Resource Effective Bioidentification System (REBS).

Freek Blanken, PhD, Microsafe Laboratories, The Netherlands

Freek studied at the University of Leiden. 2010 he started his career at the Microsafe Laboratories as Operator Molecular Biology/Mycoplasma. In 2010 he became Supervisor Molecular Biology there.
 

Dr Renato Biffi, Euofind Biolab, Italy

Renato Biffi studied Biology at the University of Milano. 2002-2003 he was research assistant at the Temple University. 2003 – 2007 he was a postdoctoral fellowship at the Don Gnocchi Foundation. 2007 he joined Eurofins wher he works currently as molecular biology laboratory manager.

Benoit Ramond, Sanofi, France

Benoit Ramond is Doctor in Pharmacy at the University of Paris XI in France and obtains a PhD in Microbiology. He has 25 years of experiences in the Pharmaceutical Industry. Since 2004 he is microbiology expert in Sanofi group. In his function he has also a leading role in the RMM strategy development within Sanofi group.


Dr Arnaud Carlotti, Eurofins IDmyk, France

Arnaud Carlotti completed his PhD at the University of Lyon, France, with a speciality in Microbiology. In 2000, he established the IDmyk service companyand. Arnaud Carlotti is president of the Eurofins IDmyk company, a competence center for detection, identification and typing of micro-organisms in pharma industries.


Jan-Oliver Karo, Paul-Ehrlich-Institut, German Federal Institute for Vaccines and Biomedicines

Oliver studied biology at the Technical University in  Darmstadt with focus on microbiology. Since 2009 he is at the Paul-Ehrlich-Institut, in the Division Microbial Safety. He is quality assessor and national expert advisor for the microbial safety of advanced therapy medicinal products (ATMPs) and member of the “Cell Therapy Products” Working Party of the German Pharmacopoeia Commission.


Dr Sven M. Deutschmann, Roche Diagnostics GmbH, Germany

Sven is Director of the Micro- and Cellbiology QC Department in the Pharma Division at Roche Diagnostics GmbH. He is member of several national and international Pharmacopoeial Expert Groups and chairman of the advisory board of the ECA “Rapid Microbiological Methods Working Group”.


Jörg Dressler, PMT GmbH, Germany

Joerg Dressler studied physics at the University Dusseldorf. 1999 he joined PMT - Particle Measuring Technique where he became head of sales and marketing. Since 2003, he is a member oft he company management and responsible for all activities in sales, marketing and service.


Dr Wolfgang Eder, Roche Diagnostics, Germany

Wolfgang studied and graduated in microbiology at the University Regensburg. After working at Diversa Corporation in USA, profos AG and University Regensburg, Germany, he joined 2006 Roche. Currently he is group leader QC EM and Cleaning at Roche Diagnostics, Penzberg, Germany.


Gerhard Haake, QA Microbiology, Sartoius Stedim Biotech GmbH, Germany

Gerhard Haake studied at the university of applied science in Münster/Germany with the degree graduate ecotrophologist. After his studies  he started working in the Quality Assurance at Sartorius Stedim Biotech GmbH as a Laboratory Manager of the Microbiological Laboratory. He is a member of the PDA Mycoplasma Filtration Group, an ISO delegate for water microbiology and member of some national committees for microbiological
issues.


Prof Dr Edwin R. van den Heuvel, Professor of Statistics at the mathematics department of the Eindhoven University of Technology

Edwin received his M.Sc. degree in mathematics and his Ph.D. in statistics from the University of Amsterdam. In 2002 he became departmental head of the statistical department of MSD (formerly Organon). He became a full professor in medical statistics at the University of Groningen in 2010 and from October 1, 2014, he will be Professor of Statistics at the mathematics department of the Eindhoven University of Technology (TU/e).


Dr Pieta C. IJzerman-Boon, MSD, The Netherlands

Pieta C. IJzerman-Boon received her education at the University of Twente, the Netherlands. In 1995 she obtained her M.Sc. degree in Applied Mathematics, followed by a Ph.D. in Statistics in 1999. She joined MSD after her PhD. In 2011 she moved to the non-clinical statistics group in the company, where she currently works as a senior statistician at the Center for Mathematical Sciences.



Dr Holger Kühn, BioChem GmbH, Germany

Holger studied Biology at the Universities of Heidelberg and Glasgow. He graduated in Regensburg. 2008-2011 he worked at SGS Institute Fresenius as Project Manager. Since 2011 he is Head of Laboratory Microbiology and Molecular Biology at BioChem GmbH in Karlsruhe.


Dr Kerstin Kleinschmidt, Novartis Pharma Stein, Switzerland

Kerstin holds a Master’s degree in Biotechnology from the Beuth Hochschule fur Technik, Berlin (Germany). Currently, Kerstin is working as a PhD Student in the RMM team of Dr David Roesti at Novartis Pharma Stein AG, Switzerland.


Dr Fabio La Neve, Merck Serono Global Manufacturing & Supply, Italy

Fabio La Neve is responsible of the Next Generation Technologies Lab (Biological Quality Control group) at the Merck-Serono plant in Ivrea, Italy. Before working in the Next Generation Technology field he was involved in the development of a NAT method for the Mycoplasma detection. Prior to joining Merck-Serono, he took his Ph.D at University of Turin in collaboration with the U.S. Food and Drug Administration research center in Laurel, MD (USA).


Kevin Luongo, Shire, USA

Kevin Luongo has over 10 years of experience in the biopharmaceutical industry. He has a broad range of experience in the evaluation and implementation of new technologies into biopharmaceutical operations. He currently works for Shire as a Scientist based in Lexington, Massachusetts and has previously worked for both Pfizer and Wyeth.


Len van Lin, MSD, The Netherlands

Len van Lin has a B.Sc. degree in Applied Sciences, specialized in Medical Microbiology. After his graduation in 2007 he joined MSD for the implementation of rapid microbiological methods.In 2014 he started as project lead with the development within the Center of expertise Microbiology for a rapid bioburden method using filtration and initializing a method transfer globally.


Rocco Petrizzo, M.Sc , TSI Spain

Rocco studied at the Universities of Modena, Catania and Barcelona. After working at Aldeasa he joined 2007 GE Healthcare as technical Support Specialist. Currently he is EMEA Contamination Control Application Specialist.


Dr Erika Pfeiler, FDA, United States

Erika has worked with FDA’s Center for Drug Evaluation  and Research for 3 years, and has review experience with rapid microbiological methods. Erika holds a Ph.D. from North Carolina State University and a B.S. in Agriculture from the University of Tennessee.


Dr David Roesti, Novartis Pharma Stein AG , Switzerland

David holds a PhD in microbial ecology from the University of Neuchatel, Switzerland. Currently, David is leading the RMM team and the Novartis Pharma expert network in microbiology at Novartis Pharma AG in Stein Switzerland. Prior to this assignment, David was the laboratory supervisor for the microbiological testing of non-sterile drug products at Novartis Pharma Stein AG.


Prof Renate Rosengarten, DVM, PhD, University of Veterinary Medicine Vienna | CSO, COO - Mycoplasma Biosafety Services, Austria

Renate Rosengarten’s academic career is for more than 35 years marked by a continuous interest in the infection biology of mycoplasmas. Since 1996 Renate Rosengarten is Professor of Bacteriology and Hygiene at the University of Veterinary Medicine Vienna in Austria. She was Founder and Managing Director of the former Mycosafe Diagnostics GmbH, and is currently CSO and COO of the newly established biosafety company Mycoplasma Biosafety Services GmbH.


Dr Alexandra Scholz, Sartorius Stedim Biotech GmbH, Germany

Alexandra holds a Masters degree in Biotechnology from the Technical University of Braunschweig (Germany) and a PhD in Live Science from the University of Hannover (Germany). She did her PhD in cooperation with Sartorius Stedim Biotech were she started working as scientist in the department of R&D Microbiology in February 2014.


Henrik Salling, Novo Nordisk, Denmark

Graduated in 2010 from University of Copenhagen. Employed by ''Statens Serum Institut'' as a molecular biologist to design qPCR assays for detection of residual host cell DNA. Employed as a development scientist by Novo Nordisk A/S to design qPCR assays for detection of viruses and mycoplasma.


Dr Melanie Stoermer, University Hospital of Cologne, Germany

After studying at the University of Applied Sciences Lippe and Hoexter, Lemgo andat the university of Bielefeld, she worked at the Institute of Laboratory and Transfusion Medicine at the Heart and Diabetes Center North Rhine-Westphalia in Bad Oeynhausen, Germany. After her doctoral thesis she was employed at the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, in the Division Microbial Safety. Since April 2011 she is working at the Institute for Transfusion Medicine at the University Hospital of Cologne and is responsible for the scientific work dealing with quality of blood products and stem cells.